MSD
The Senior Scientist will join the Quantitative Pharmacology and Pharmacometrics (QP2) department to support cardiometabolic and ophthalmology pipelines. The role involves developing model‑based strategies, representing QP2 on cross‑functional teams, and collaborating with internal and external partners to drive drug discovery and development decisions.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
10% below the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Senior Scientist
Merck & Co., Inc.
Senior Scientist, Quantitative Pharmacology and Pharmacometrics – Immune/Oncology
Merck & Co., Inc.
Senior Scientist, Quantitative Pharmacology and Pharmacometrics – Immune/Oncology
Merck & Co., Inc.
Associate Director, Quantitative Pharmacology and Pharmacometrics
Merck & Co., Inc.
Associate Director, Quantitative Pharmacology and Pharmacometrics – Immune/Oncology (QP2-IO)
Merck & Co., Inc.
Senior Director, Group Leader
Merck & Co., Inc.